Breadcrumb Inicio Studies Studies Search Filter Research Area All Study Status AllClosed to AccrualClosed to Follow UpConcludedEnrollingIn DevelopmentParticipants Off Study and Primary Analysis CompletedPending Sort Study Number AscStudy Number Desc Submit Search Showing 127 studies. P1021: FTC + EFV + ddI Didanosine QD in Naive Children DAIDS Number 10038 Research Area Other Study Status Concluded P1020A: A Phase I/II, Open-Label, Pharmacokinetic and Safety Study of a Novel Protease Inhibitor (BMS-232632, Atazanavir, ATV, Reyataz) in Combination Regimens in Antiretroviral Therapy (ART)-Naive and Experienced HIV-infected Infants, Children and Adolescents DAIDS Number 10037 Research Area Treatment Study Status Concluded P1018: Single Dose Pk Study of Abacavir in HIV-Infected Children and Adolescents DAIDS Number 10268 Research Area Other Study Status Concluded P1017: PEG-Intron in HIV+Children DAIDS Number 10317 Research Area Other Study Status Concluded P1015: Cycling HAART in Pediatric/Adolescent Patients with < 50 HIV RNA copies/mL. DAIDS Number 10267 Research Area Other Study Status Concluded P1013: Salvage Therapy With Combination PJ's, Ritonavir, and Indinavir DAIDS Number 10191 Research Area Other Study Status Concluded P1012: PK Study of Once Versus Twice Dosing with Combivir DAIDS Number 10266 Research Area Other Study Status Concluded P1011: Serostim Growth Hormone Dose-Finding Study in Children With HIV DAIDS Number 10316 Research Area Other Study Status Concluded P1010: Effect of Antiretroviral Therapy on Body Composition in Children. DAIDS Number 10814 Research Area Other Study Status Concluded P1008: Rate of OI Events in Stable Kids DAIDS Number 10264 Research Area Other Study Status Concluded Pagination Previous page Prev Página 1 … Página 5 Página 6 Página 7 Página 8 Página 9 Página 10 Página 11 Current page 12 Página 13 Next page Next
P1021: FTC + EFV + ddI Didanosine QD in Naive Children DAIDS Number 10038 Research Area Other Study Status Concluded
P1020A: A Phase I/II, Open-Label, Pharmacokinetic and Safety Study of a Novel Protease Inhibitor (BMS-232632, Atazanavir, ATV, Reyataz) in Combination Regimens in Antiretroviral Therapy (ART)-Naive and Experienced HIV-infected Infants, Children and Adolescents DAIDS Number 10037 Research Area Treatment Study Status Concluded
P1018: Single Dose Pk Study of Abacavir in HIV-Infected Children and Adolescents DAIDS Number 10268 Research Area Other Study Status Concluded
P1015: Cycling HAART in Pediatric/Adolescent Patients with < 50 HIV RNA copies/mL. DAIDS Number 10267 Research Area Other Study Status Concluded
P1013: Salvage Therapy With Combination PJ's, Ritonavir, and Indinavir DAIDS Number 10191 Research Area Other Study Status Concluded
P1012: PK Study of Once Versus Twice Dosing with Combivir DAIDS Number 10266 Research Area Other Study Status Concluded
P1011: Serostim Growth Hormone Dose-Finding Study in Children With HIV DAIDS Number 10316 Research Area Other Study Status Concluded
P1010: Effect of Antiretroviral Therapy on Body Composition in Children. DAIDS Number 10814 Research Area Other Study Status Concluded
P1008: Rate of OI Events in Stable Kids DAIDS Number 10264 Research Area Other Study Status Concluded
